Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FSME8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,168
Award facts
- Contract value 100% obligated
- $33,168.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,168.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The award was issued on December 12, 2025, with an ultimate completion date of January 6, 2026, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform this delivery order from its Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy. The parent contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products and biologics to support Department of Defense healthcare operations globally. Stelara is an immunosuppressant biologic included within the contractor's authorized product portfolio for military medical facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FSME8?
SPE2DR26FSME8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FSME8 worth?
The government has obligated $33,168 on SPE2DR26FSME8.
Is contract SPE2DR26FSME8 an order under another contract?
Yes. SPE2DR26FSME8 is a delivery order under SPE2DR25D9320, an indefinite delivery contract.
Was contract SPE2DR26FSME8 competed?
The extent of competition for SPE2DR26FSME8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award